Veeva Systems, Inc.
4637 Chabot Drive
Suite 210
Pleasanton
California
94588
United States
Tel: 925-452-6500
Fax: 925-452-6504
Website: http://www.veevasystems.com/
392 articles about Veeva Systems, Inc.
-
Veeva Vault EDC Surpasses 1,000 Study Start Milestone
3/20/2024
Veeva Systems (NYSE: VEEV) today announced that Veeva Vault EDC powered more than 1,000 study starts.
-
Boehringer Ingelheim Partners with Veeva to Advance its Clinical and Regulatory Operations in Animal Health
2/14/2024
Veeva Systems announced that Boehringer Ingelheim has selected Veeva Vault Clinical and Veeva Vault RIM applications as its technology foundation for clinical and regulatory management in its animal health business unit.
-
Veeva Completes Study Migrations to Veeva Vault EDC for Top Biopharma
1/17/2024
Veeva Systems (NYSE: VEEV) today announced a top 20 biopharma and Veeva Services migrated 25 ongoing clinical studies to Veeva Vault EDC from a legacy electronic data capture (EDC) application.
-
Leading Pharma Adopts Veeva Vault Validation Management for Digital Validation Execution and Improved Efficiency
1/11/2024
Veeva Systems announced that SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co. Ltd., a global biotech company, is using Veeva Vault Validation Management to streamline and accelerate their validation process.
-
Top Biopharma Commits to Veeva Vault CRM for Global Customer Engagement
11/27/2023
Veeva Systems (NYSE: VEEV) today announced that GSK will be one of the first top biopharma companies to migrate to Veeva Vault CRM.
-
Bayer Commits to Veeva Vault CRM and Veeva OpenData Globally
11/27/2023
Veeva Systems (NYSE: VEEV) today announced that Bayer will be among the first top 20 biopharmas to move to Veeva Vault CRM worldwide, while also standardizing global customer data with Veeva OpenData.
-
LEO Pharma Connects Affiliates with Veeva Vault Safety to Transform Safety Operations
10/3/2023
Veeva Systems (NYSE: VEEV) today announced that LEO Pharma , a global leader in medical dermatology, is using Veeva Vault Safety to optimize its safety operations.
-
Veeva Pulse Uncovers Field Medical Engagement Drives 1.5x Increase in Treatment Adoption
7/26/2023
Veeva Systems revealed findings of field medical's impact on clinical practice in the Veeva Pulse Field Trends Report.
-
Merck KGaA, Darmstadt, Germany Partners with Veeva to Transform Medical Information Operations Globally
7/12/2023
Veeva Systems (NYSE: VEEV) today announced that Merck KGaA, Darmstadt, Germany is using Veeva Vault MedInquiry as its global medical information management system.
-
Veeva Announces Fiscal 2024 First Quarter Results
5/31/2023
Veeva Systems Inc., a leading provider of industry cloud solutions for the global life sciences industry, announced results for its first quarter ended April 30, 2023.
-
Lotus Clinical Research Expands Partnership with Veeva to Accelerate Clinical Trials
5/30/2023
Veeva Systems (NYSE: VEEV) today announced that Lotus Clinical Research expanded its partnership with Veeva and broadened its adoption of Veeva Vault Clinical Suite, a strategic move to strengthen its service delivery and efficiency.
-
Minaris Regenerative Medicine Streamlining Contract Manufacturing with Veeva Vault Quality Suite Applications
5/24/2023
Veeva Systems (NYSE: VEEV) today announced that Minaris Regenerative Medicine selected Veeva Vault QualityDocs and Veeva Vault Training to advance its global quality operations.
-
UCB and Veeva Collaborate to Advance the Patient Experience in Clinical Trials
5/23/2023
Veeva Systems (NYSE: VEEV) and UCB , a global biopharmaceutical company, today announced a collaboration that will focus on technology-driven solutions aimed at improving the patient experience and trial efficiency.
-
New Veeva Link MedTech Provides Real-Time Data to Optimize Scientific Engagement
5/18/2023
Veeva Systems (NYSE: VEEV) today announced Veeva Link MedTech , a data application developed for medtech companies to identify scientific experts, personalize engagement, and map activities across the healthcare ecosystem.
-
Life Sciences Brands Reach Clinically Relevant Audiences with New Veeva Crossix Prime Segments
4/20/2023
Veeva Systems (NYSE: VEEV) today announced Veeva Crossix Prime Segments, a new solution helping life sciences brands improve media efficiency and better target patients by reaching more highly-qualified health audiences.
-
Veeva MedTech Clinical Trials Report Signals Significant Opportunity to Improve Data Delivery and Quality
4/19/2023
Veeva Systems (NYSE: VEEV) today released its first-ever report examining global trends in medtech clinical trials. According to the 2023 Veeva MedTech Clinical Benchmark Report.
-
Veeva Commercial Summit Connects Nearly 1,500 Life Sciences Leaders Across Sales, Medical, and Marketing
4/18/2023
Veeva Systems announced that leaders from Bristol Myers Squibb, Eli Lilly and Company, Genentech, Janssen, and Merck will be keynote speakers at the 2023 Veeva Commercial Summit on May 2-3 in Boston.
-
Veeva Announces Fiscal 2023 Third Quarter Results
12/1/2022
Veeva Systems Inc., a leading provider of industry cloud solutions for the global life sciences industry, announced results for its third quarter ended October 31, 2022.
-
Top Biopharmas Elevate Medical Engagement with Veeva Link Scientific Awareness
11/23/2022
Veeva Systems (NYSE: VEEV) today announced three of the top ten biopharmas now use the recently released Veeva Link Scientific Awareness for real-time intelligence on product awareness and sentiment.
-
Veeva and Merck Form Long-Term Strategic Partnership
11/1/2022
Veeva Systems (NYSE: VEEV) today announced a ten-year strategic partnership agreement with Merck.